Fig. 8

Exploration of Potential Therapeutic Agents for Patients with High GloMICS (A) Gene Set Enrichment Analysis (GSEA) investigates the distribution and significance of differentially expressed genes within known biological pathways. (B) Demonstrating the predicted sensitivity of the chemotherapy drug Temozolomide for glioblastoma multiforme (GBM) samples. (C) The workflow for screening potential therapeutic agents. (D and E) Correlation and differential analysis of drug sensitivity for potential drugs screened from the CTRP and PRISM datasets.